Anavex Life Sciences Corp (AVXL)

[falconer66a]

Facts and experts of no consideration.

I wish some independent scientific article and maybe even the RETT association comes out with the right assessment of the results and state how excited they are.

No, any of that would be “news,” only. Until a company has revenues, against which a share price can be compared, as presently the case, the share price will swing wildly, mostly downward. Doesn’t make sense, but it’s what happens. Has happened virtually every time “real news” comes out about Anavex.

Look at the factual postings today. Several renowned medical experts, MDs and PhDs working in CNS diseases, have plainly stated that blarcamesine is now a therapeutic success against Rett syndrome. But at this early drug development stage, people working AVXL share prices pay no attention to “experts” or “scholarly papers.”

Watch. When the Rett support organization comes out with a positive statement there will be immediate (pre-written) postings about how results actually were weak, cherry-picked, and insufficient for FDA approval.

The people who know have already taken and continue to hold their AVXL positions; many of us “perma-bulls” here, along with an increasing number of institutional buyers. For us, collectively and affirmatively, we see over the cluttered day-trading horizon to a fantastic Anavex future. Years out, not days, weeks, or months. A matter of time perspective.